IOVA stock results show that Iovance Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
Articles
LGF-B Stock Earnings: Lions Gate Entertainment Corporation Class B Non-Voting Shares Beats EPS, Misses Revenue for Q1 2025
LGF-B stock results show that Lions Gate Entertainment Corporation Class B Non-Voting Shares beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025. More
LGF-A Stock Earnings: Lions Gate Entertainment Corporation Class A Voting Shares Beats EPS, Misses Revenue for Q1 2025
LGF-A stock results show that Lions Gate Entertainment Corporation Class A Voting Shares beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025. More
GRNT Stock Earnings: Granite Ridge Resources Misses EPS, Misses Revenue for Q2 2024
GRNT stock results show that Granite Ridge Resources missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
ARLO Stock Earnings: Arlo Technologies Beats EPS, Beats Revenue for Q2 2024
ARLO stock results show that Arlo Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
VRRM Stock Earnings: Verra Mobility Beats EPS, Beats Revenue for Q2 2024
VRRM stock results show that Verra Mobility beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
CHRS Stock Earnings: Coherus BioSciences Beats EPS, Beats Revenue for Q2 2024
CHRS stock results show that Coherus BioSciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
